BEAM
Beam Therapeutics Inc. Healthcare - Biotechnology Investor Relations →
Beam Therapeutics Inc. (BEAM) closed at $26.52 as of 2026-02-02, trading 12.9% below its 200-week moving average of $30.45. This places BEAM in the extreme value zone. The stock is currently moving closer to the line, down from -9.7% last week. The 14-week RSI sits at 54, indicating neutral momentum.
Over the past 265 weeks of data, BEAM has crossed below its 200-week moving average 4 times. On average, these episodes lasted 50 weeks. The average one-year return after crossing below was -41.5%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $2.7 billion, BEAM is a mid-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -47.2%. The stock trades at 2.7x book value.
Share count has increased 22.3% over three years, indicating dilution.
Over the past 5.2 years, a hypothetical investment of $100 in BEAM would have grown to $28, compared to $200 for the S&P 500. BEAM has returned -22.1% annualized vs 14.3% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: BEAM vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After BEAM Crosses Below the Line?
Across 3 historical episodes, buying BEAM when it crossed below its 200-week moving average produced an average return of -41.7% after 12 months (median -49.0%), compared to +0.0% for the S&P 500 over the same periods. After 24 months, the average return was -50.7% vs +25.7% for the index.
Each line shows $100 invested at the moment BEAM crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
BEAM has crossed below its 200-week MA 4 times with an average 1-year return of +-41.5% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jan 2022 | Feb 2022 | 1 | 1.3% | -21.0% | -56.8% |
| Mar 2022 | Jul 2022 | 19 | 45.2% | -47.2% | -56.5% |
| Aug 2022 | Jan 2026 | 178 | 66.4% | -56.2% | -50.2% |
| Jan 2026 | Ongoing | 2+ | 12.9% | Ongoing | -4.0% |
| Average | 50 | — | +-41.5% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02